Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interstitial lung disease in systemic sclerosis.

B Marasini1, L Belloli, M Massarotti

  • 1Rheumatology Unit, Humanitas Clinical Institute, IRCCS, University of Milan, Italy. bianca.marasini@humanitas.it

International Journal of Immunopathology and Pharmacology
|July 13, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness.

Communications biology·2024
Same author

Multimodal assessment improves neuroprognosis performance in clinically unresponsive critical-care patients with brain injury.

Nature medicine·2024
Same author

PerBrain: a multimodal approach to personalized tracking of evolving state-of-consciousness in brain-injured patients: protocol of an international, multicentric, observational study.

BMC neurology·2022
Same author

Outbreak Investigation of Influenza in Pajaru VDC of Jajarkot District of Nepal.

Journal of Nepal Health Research Council·2017
Same author

Effects of type II collagen epitope carbamylation and citrullination in human leucocyte antigen (HLA)-DR4(+) monozygotic twins discordant for rheumatoid arthritis.

Clinical and experimental immunology·2016
Same author

Osteoanabolic therapy: a valid option to reduce refracture risk after vertebral augmentation procedures?

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016
Same journal

Glycolysis and neutrophil extracellular traps in atherosclerosis: Mechanisms, association, and therapeutic strategies.

International journal of immunopathology and pharmacology·2026
Same journal

Development of RNase P ribozyme-based therapy against oral herpesvirus infections by HSV-1 and KSHV.

International journal of immunopathology and pharmacology·2026
Same journal

Liposomal nanotherapeutics for cancer treatment: Targeted delivery and immunotherapy.

International journal of immunopathology and pharmacology·2026
Same journal

Apoptosis enhancement in MCF-7 cells: Synergistic effects of doxorubicin and the novel sulfonamide Zm-093.

International journal of immunopathology and pharmacology·2026
Same journal

Primary epithelioid angiosarcoma of thyroid: A case report and review of literature.

International journal of immunopathology and pharmacology·2026
Same journal

Retraction: Adipose stem cells' antagonism in glycosylation of D-galactose-induced skin aging of nude mice and its skin recovery function.

International journal of immunopathology and pharmacology·2026
See all related articles

Early diagnosis of interstitial lung disease in systemic sclerosis (SSc) is crucial for effective treatment during the inflammatory phase. Identifying at-risk patients remains challenging, necessitating vigilant monitoring and further research into novel therapies.

Area of Science:

  • Rheumatology
  • Pulmonology
  • Internal Medicine

Background:

  • Interstitial lung disease (ILD) is a significant and early complication of systemic sclerosis (SSc).
  • ILD in SSc can be asymptomatic for extended periods, complicating early detection.
  • The inflammatory phase of ILD offers the best window for therapeutic intervention.

Purpose of the Study:

  • To highlight the critical need for early diagnosis and risk identification of ILD in SSc patients.
  • To emphasize the importance of strict monitoring, particularly in the initial years of SSc.
  • To discuss current treatment strategies and the need for further research.

Main Methods:

  • Review of current understanding of ILD in SSc.
  • Analysis of diagnostic challenges and monitoring requirements.

Related Experiment Videos

  • Evaluation of existing treatment paradigms and future research directions.

    • Main Results:

    • Early detection of ILD in SSc is vital for improving patient outcomes.
    • Identifying patients at high risk for developing ILD is currently difficult.
    • Current treatment focuses on suppressing inflammation, with combination therapy of corticosteroids and cyclophosphamide being the preferred approach.

    Conclusions:

    • Strict monitoring of SSc patients is mandatory for early ILD detection.
    • Optimal treatment strategies for SSc-ILD are not yet established.
    • Future research should explore novel anti-inflammatory and immunosuppressive agents for SSc-ILD.